Early	O
life	O
vaccination	B:C0042196
:	O
Generation	O
of	O
adult	O
-	O
quality	O
memory	O
CD8	O
+	I:C0242629

Early	O
life	O
vaccination	O
:	O
Generation	O
of	O
adult	O
-	O
quality	O
memory	B:C0682639
CD8	O
+	I:C0242629

Early	O
life	O
vaccination	O
:	O
Generation	O
of	O
adult	O
-	O
quality	O
memory	O
CD8	B:C0242629
+	I:C0242629

T	I:C0242629
cells	I:C0242629
in	O
infant	B:C0920362
mice	O
using	O
non-replicating	O
adenoviral	O
vectors	I:C1510800
Intracellular	O
pathogens	O
represent	O
a	O
serious	O
threat	O
during	O
early	O
life	O
.	O

T	I:C0242629
cells	I:C0242629
in	O
infant	O
mice	B:C0025929
using	O
non-replicating	O
adenoviral	O
vectors	I:C1510800
Intracellular	O
pathogens	O
represent	O
a	O
serious	O
threat	O
during	O
early	O
life	O
.	O

T	I:C0242629
cells	I:C0242629
in	O
infant	O
mice	O
using	O
non-replicating	B:C1511692
adenoviral	O
vectors	I:C1510800
Intracellular	O
pathogens	O
represent	O
a	O
serious	O
threat	O
during	O
early	O
life	O
.	O

T	I:C0242629
cells	I:C0242629
in	O
infant	O
mice	O
using	O
non-replicating	O
adenoviral	B:C1510800
vectors	I:C1510800
Intracellular	O
pathogens	O
represent	O
a	O
serious	O
threat	O
during	O
early	O
life	O
.	O

T	I:C0242629
cells	I:C0242629
in	O
infant	O
mice	O
using	O
non-replicating	O
adenoviral	O
vectors	I:C1510800
Intracellular	B:C0178719
pathogens	O
represent	O
a	O
serious	O
threat	O
during	O
early	O
life	O
.	O

Importantly	O
,	O
even	O
though	O
the	O
immune	B:C0020962
system	I:C0020962
of	O
newborns	O
may	O
be	O
characterized	O
as	O
developmentally	O
immature	O
,	O
with	O
a	O
propensity	O
to	O
develop	O
Th2	O
immunity	O
,	O
significant	O
CD8	O
+	I:C0242629

Importantly	O
,	O
even	O
though	O
the	O
immune	O
system	I:C0020962
of	O
newborns	O
may	O
be	O
characterized	O
as	O
developmentally	B:C0243107
immature	O
,	O
with	O
a	O
propensity	O
to	O
develop	O
Th2	O
immunity	O
,	O
significant	O
CD8	O
+	I:C0242629

Importantly	O
,	O
even	O
though	O
the	O
immune	O
system	I:C0020962
of	O
newborns	O
may	O
be	O
characterized	O
as	O
developmentally	O
immature	O
,	O
with	O
a	O
propensity	O
to	O
develop	O
Th2	B:C0242633
immunity	O
,	O
significant	O
CD8	O
+	I:C0242629

Importantly	O
,	O
even	O
though	O
the	O
immune	O
system	I:C0020962
of	O
newborns	O
may	O
be	O
characterized	O
as	O
developmentally	O
immature	O
,	O
with	O
a	O
propensity	O
to	O
develop	O
Th2	O
immunity	B:C0020964
,	O
significant	O
CD8	O
+	I:C0242629

Importantly	O
,	O
even	O
though	O
the	O
immune	O
system	I:C0020962
of	O
newborns	O
may	O
be	O
characterized	O
as	O
developmentally	O
immature	O
,	O
with	O
a	O
propensity	O
to	O
develop	O
Th2	O
immunity	O
,	O
significant	O
CD8	B:C0242629
+	I:C0242629

T	I:C0242629
-	I:C0242629
cell	I:C0242629
responses	B:C1318468
may	O
still	O
be	O
elicited	O
in	O
the	O
context	O
of	O
optimal	O
priming	O
.	O

Replication	B:C1511692
deficient	I:C1511692
adenoviral	O
vectors	I:C1510800
have	O
been	O
demonstrated	O
to	O
induce	O
potent	O
CD8	O
+	I:C0242629

Replication	O
deficient	I:C1511692
adenoviral	B:C1510800
vectors	I:C1510800
have	O
been	O
demonstrated	O
to	O
induce	O
potent	O
CD8	O
+	I:C0242629

Replication	O
deficient	I:C1511692
adenoviral	O
vectors	I:C1510800
have	O
been	O
demonstrated	O
to	O
induce	O
potent	O
CD8	B:C0242629
+	I:C0242629

T	I:C0242629
-	I:C0242629
cell	I:C0242629
response	B:C1318468
in	O
mice	O
,	O
primates	O
and	O
humans	O
.	O

T	I:C0242629
-	I:C0242629
cell	I:C0242629
response	O
in	O
mice	B:C0026809
,	O
primates	O
and	O
humans	O
.	O

T	I:C0242629
-	I:C0242629
cell	I:C0242629
response	O
in	O
mice	O
,	O
primates	B:C0033147
and	O
humans	O
.	O

T	I:C0242629
-	I:C0242629
cell	I:C0242629
response	O
in	O
mice	O
,	O
primates	O
and	O
humans	B:C0086418
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
therefore	O
to	O
assess	O
whether	O
replication	B:C1511692
-	I:C1511692
deficient	I:C1511692
adenovectors	O
could	O
overcome	O
the	O
risk	O
of	O
overwhelming	O
antigen	O
stimulation	I:C2250751
during	O
the	O
first	O
period	O
of	O
life	O
and	O
provide	O
a	O
pertinent	O
alternative	O
in	O
infant	O
vaccinology	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
therefore	O
to	O
assess	O
whether	O
replication	O
-	I:C1511692
deficient	I:C1511692
adenovectors	B:C1510800
could	O
overcome	O
the	O
risk	O
of	O
overwhelming	O
antigen	O
stimulation	I:C2250751
during	O
the	O
first	O
period	O
of	O
life	O
and	O
provide	O
a	O
pertinent	O
alternative	O
in	O
infant	O
vaccinology	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
therefore	O
to	O
assess	O
whether	O
replication	O
-	I:C1511692
deficient	I:C1511692
adenovectors	O
could	O
overcome	O
the	O
risk	O
of	O
overwhelming	O
antigen	B:C2250751
stimulation	I:C2250751
during	O
the	O
first	O
period	O
of	O
life	O
and	O
provide	O
a	O
pertinent	O
alternative	O
in	O
infant	O
vaccinology	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
therefore	O
to	O
assess	O
whether	O
replication	O
-	I:C1511692
deficient	I:C1511692
adenovectors	O
could	O
overcome	O
the	O
risk	O
of	O
overwhelming	O
antigen	O
stimulation	I:C2250751
during	O
the	O
first	O
period	O
of	O
life	O
and	O
provide	O
a	O
pertinent	O
alternative	O
in	O
infant	O
vaccinology	B:C0042196
.	O

To	O
address	O
this	O
,	O
infant	B:C0920362
mice	O
were	O
vaccinated	O
with	O
three	O
different	O
adenoviral	O
vectors	I:C1510800
and	O
the	O
CD8	O
+	I:C0242629

To	O
address	O
this	O
,	O
infant	O
mice	B:C0025929
were	O
vaccinated	O
with	O
three	O
different	O
adenoviral	O
vectors	I:C1510800
and	O
the	O
CD8	O
+	I:C0242629

To	O
address	O
this	O
,	O
infant	O
mice	O
were	O
vaccinated	B:C1519885
with	O
three	O
different	O
adenoviral	O
vectors	I:C1510800
and	O
the	O
CD8	O
+	I:C0242629

To	O
address	O
this	O
,	O
infant	O
mice	O
were	O
vaccinated	O
with	O
three	O
different	O
adenoviral	B:C1510800
vectors	I:C1510800
and	O
the	O
CD8	O
+	I:C0242629

To	O
address	O
this	O
,	O
infant	O
mice	O
were	O
vaccinated	O
with	O
three	O
different	O
adenoviral	O
vectors	I:C1510800
and	O
the	O
CD8	B:C0242629
+	I:C0242629

T	I:C0242629
-	I:C0242629
cell	I:C0242629
response	B:C1318468
after	O
early	O
life	O
vaccination	O
was	O
explored	O
.	O

T	I:C0242629
-	I:C0242629
cell	I:C0242629
response	O
after	O
early	O
life	O
vaccination	B:C0042196
was	O
explored	O
.	O

We	O
assessed	O
the	O
frequency	O
,	O
polyfunctionality	O
and	O
in	O
vivo	O
cytotoxicity	B:C0596402
of	O
the	O
elicited	O
memory	O
CD8	O
+	I:C0242629

We	O
assessed	O
the	O
frequency	O
,	O
polyfunctionality	O
and	O
in	O
vivo	O
cytotoxicity	O
of	O
the	O
elicited	O
memory	B:C0682639
CD8	O
+	I:C0242629

We	O
assessed	O
the	O
frequency	O
,	O
polyfunctionality	O
and	O
in	O
vivo	O
cytotoxicity	O
of	O
the	O
elicited	O
memory	O
CD8	B:C0242629
+	I:C0242629

T	I:C0242629
cells	I:C0242629
,	O
as	O
well	O
as	O
the	O
potential	O
of	O
these	O
cells	B:C0242629
to	O
respond	O
to	O
secondary	O
infections	I:C0442886
and	O
confer	O
protection	O
.	O

T	I:C0242629
cells	I:C0242629
,	O
as	O
well	O
as	O
the	O
potential	O
of	O
these	O
cells	O
to	O
respond	O
to	O
secondary	B:C0442886
infections	I:C0442886
and	O
confer	O
protection	O
.	O

T	I:C0242629
cells	I:C0242629
,	O
as	O
well	O
as	O
the	O
potential	O
of	O
these	O
cells	O
to	O
respond	O
to	O
secondary	O
infections	I:C0442886
and	O
confer	O
protection	B:C0150259
.	O

We	O
further	O
tested	O
the	O
impact	O
of	O
maternal	B:C1858460
immunity	O
against	O
our	O
replication	O
-	I:C1511692
deficient	I:C1511692
adenoviral	O
vector	I:C1510800
during	O
early	O
life	O
vaccination	O
.	O

We	O
further	O
tested	O
the	O
impact	O
of	O
maternal	O
immunity	B:C0020964
against	O
our	O
replication	O
-	I:C1511692
deficient	I:C1511692
adenoviral	O
vector	I:C1510800
during	O
early	O
life	O
vaccination	O
.	O

We	O
further	O
tested	O
the	O
impact	O
of	O
maternal	O
immunity	O
against	O
our	O
replication	B:C1511692
-	I:C1511692
deficient	I:C1511692
adenoviral	O
vector	I:C1510800
during	O
early	O
life	O
vaccination	O
.	O

We	O
further	O
tested	O
the	O
impact	O
of	O
maternal	O
immunity	O
against	O
our	O
replication	O
-	I:C1511692
deficient	I:C1511692
adenoviral	B:C1510800
vector	I:C1510800
during	O
early	O
life	O
vaccination	O
.	O

We	O
further	O
tested	O
the	O
impact	O
of	O
maternal	O
immunity	O
against	O
our	O
replication	O
-	I:C1511692
deficient	I:C1511692
adenoviral	O
vector	I:C1510800
during	O
early	O
life	O
vaccination	B:C0042196
.	O

Overall	O
,	O
our	O
results	O
indicate	O
that	O
memory	B:C0682639
CD8	O
+	I:C0242629

Overall	O
,	O
our	O
results	O
indicate	O
that	O
memory	O
CD8	B:C0242629
+	I:C0242629

T	I:C0242629
cells	I:C0242629
induced	O
by	O
adenoviral	B:C1510800
vectors	I:C1510800
in	O
infant	O
mice	O
are	O
of	O
good	O
quality	O
and	O
match	O
those	O
elicited	O
in	O
the	O
adult	O
host	O
.	O

T	I:C0242629
cells	I:C0242629
induced	O
by	O
adenoviral	O
vectors	I:C1510800
in	O
infant	B:C0920362
mice	O
are	O
of	O
good	O
quality	O
and	O
match	O
those	O
elicited	O
in	O
the	O
adult	O
host	O
.	O

T	I:C0242629
cells	I:C0242629
induced	O
by	O
adenoviral	O
vectors	I:C1510800
in	O
infant	O
mice	B:C0025929
are	O
of	O
good	O
quality	O
and	O
match	O
those	O
elicited	O
in	O
the	O
adult	O
host	O
.	O

